[suzierose]

Carfilzomib plus pomalidomide trial now open

by suzierose on Sun Dec 04, 2011 8:33 pm

A multi-center study to determine the safety and maximum tolerated dose of pomalidomide + carfilzomib will open Tuesday, November 15th, at the University of Indiana.

A total of ten sites will take part in this clinical trial of a new immunomodulatory drug (pomalidomide) in combination with a new proteasome inhibitor (carfilzomib).

For more about the trial, check:

http://clinicaltrials.gov/ct2/show/NCT01464034

Moderator's note: For the latest news regarding these two drugs, you may wish to consult their tag pages at:

https://myelomabeacon.org/tag/carfilzomib
https://myelomabeacon.org/tag/pomalidomide

[Dr. Peter Voorhees]

Re: carfilzomib plus pomalidomide trial now open

by Dr. Peter Voorhees on Mon Dec 05, 2011 3:03 am

Dear all,

This is a study for patients with relapsed or relapsed/refractory myeloma. It is a very important study and should be a highly active regimen. I would encourage participation for those whom it is feasible!

Pete